Evidence map›Paper›PMID 32439758›Full record

ArticleDevelopment (Cambridge, England)2020

Andreas Postlmayr, Charles Etienne Dumeau, Anton Wutz

Open access · hybridAbstract read
In one paragraph

Article in Development (Cambridge, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Genetically Engineered Mice Unveil In Vivo Roles of the Mediator Complex.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Limitations of Tamoxifen Application for In Vivo Genome Editing Using Cre/ERInternational journal of molecular sciences · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Gene regulation in time and space during X-chromosome inactivation.Nature reviews. Molecular cell biology · 2022
    Review
  14. Article
  15. Article
  16. Biological Function of Long Non-coding RNA (LncRNA) Xist.Frontiers in cell and developmental biology · 2021
    Review
  17. Article
  18. Development (Cambridge, England) · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andreas PostlmayrD-BIOL, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology, ETH Hönggerberg, HPL E12, Otto-Stern-Weg 7, 8049 Zurich, Switzerland.
Charles Etienne DumeauD-BIOL, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology, ETH Hönggerberg, HPL E12, Otto-Stern-Weg 7, 8049 Zurich, Switzerland.
Anton WutzD-BIOL, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology, ETH Hönggerberg, HPL E12, Otto-Stern-Weg 7, 8049 Zurich, Switzerland awutz@ethz.ch.ORCID 0000-0002-4377-6330

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously identified the cyclin dependent kinase

Indexed as

AnimalsCyclin-Dependent Kinase 8Cyclin-Dependent KinasesEmbryo, MammalianEmbryonic DevelopmentEnhancer of Zeste Homolog 2 ProteinFemaleGene EditingGene Expression Regulation, DevelopmentalHistonesMaleMethylationMiceMice, TransgenicMouse Embryonic Stem CellsMutagenesisCDK19 protein, mouseCdk8 protein, mouseCyclin-Dependent Kinase 8Cyclin-Dependent KinasesEnhancer of Zeste Homolog 2 ProteinEzh2 protein, mouseHistonesPolycomb Repressive Complex 2RNA, Guide, CRISPR-Cas SystemsRNA, Long NoncodingSox2 protein, mouseSOXB1 Transcription FactorsXIST non-coding RNACdk8Cyclin dependent kinaseGene regulationPolycombX inactivationXist

Identifiers

PMID32439758
PMCPMC7295591
OpenAlexW3026648376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.